MUMBAI, India, Oct. 11 -- Intellectual Property India has published a patent application (202517090998 A) filed by Edgewise Therapeutics, Inc., Boulder, U.S.A., on Sept. 23, for 'quinolinone amide compounds and uses thereof.'
Inventor(s) include Hawryluk, Natalie Anne; Schlachter, Stephen Thomas; Koch, Kevin; Luzzio, Michael Joseph; Russell, Alan James; Evanchik, Marc Justin; Del Rio, Carlos Luis; and Hunt, Kevin.
The application for the patent was published on Oct. 10, under issue no. 41/2025.
According to the abstract released by the Intellectual Property India: "The present disclosure generally relates to substituted quinolinone amide compounds or salts of Formula (I), (II-A), (IV), or (III) and pharmaceutical compositions thereof. Th...